SlideShare a Scribd company logo
1 of 15
PLASMA HALF LIFE
I
DEFINITION
• It is the time period required for the amount
of or the concentration of a drug to fall to
50 % of the earlier measurement.
• or
• It is the time required to achieve half of the
concentration of drug in the plasma
administered via any route.
Types of half life
• Biological half life
• Plasma half life
• Distribution half life
• Elimination half life
BIOLOGICAL HALF LIFE;
• It is the general term which implies to the
time period in which the initial concentration
of the drug decreases by one half.[it is not
specific for any anatomical compartment or
for any process of elimination].
PLASMA HALF LIFE
• It is the time required to decrease the drug
concentration in the plasma to one half of its
initial concentration.
• or
• To achieve half of the concentration the drug
in the plasma after administration via any
route.
• It is denoted by t1/2
DISTRIBUTION HALF LIFE
• It is the time taken to decrease the drug
concentration in the plasma to one half of its
initial concentration by virtue of its
distribution [to the other compartments].
ELIMINATION HALF LIFE
It is the time taken when one half of the drug
appears in the urine or bile.
• Elimination half life is expressed as
• t ½= 0.693 X Vd/CL
• Where CL is the clearence and Vd is the
volume of distribution.
Contd
Changes in the plasma conc. On starting ,
altering or stopping the drug administration
can be predicted by plasma half life.
INFUSION AT A CONSTANT
RATE
• When a drug is infused at a constant rate, the
rate of elimination becomes equal to the rate
of administration and a steady state is
achieved called the STEADY STATE
CONCENTRATION.
• This is depicted by a PLATEAU on the conc
time curve.
ON WITHDDRAWL OF THE DRUG
• On stopping the drug , the plasma conc goes
on decreasing as follows:
• In the first half life [ t ½] = To 5o%
• In the second half life [ 2t ½] = 25%
• In the third half life [3t ½] = 12.5%
• In the fourth half life [4t ½] = 6.25%
• In the fifth half life [5t ½] = 3.12%
• Of the original steady state conc .
SIGNIFICANCE OF THE HALF
LIFE
• To determine the duration of action of the drug.
• To evaluate the dose [by the Vd, protien binding and the
elimination]
• To determine the frequency of drug administration.
• To calculate the loading dose
• [ t ½ x tc x CL/o.693]
• To determine the time required to reach the steady concentrtation.
• To know about the maintenance dose
• [Vd x Css ½ x o.693]
• To find the defect in the distribution, metabolism or clearence[to
asses the disease]
contd
• When the protein binding of the drug is
more, it will increase the plasma half ,unless
the drug is excreted by active secretion as in
penicillin G.
• It gives an idea of the time to attain a steady
state and also the time taken for the
elimination.
• IT HELPS IN CALCULATING THE TOTAL
CLEARENCE i.e
• CL = O.693 X Vd / t ½
FACTORS EFFECTING HALF LIFE
1 Concurrent administration of another drug that displaces the
first drug from albumin decreases its t ½.
2 low extraction ratio increases the half life as in the liver and
kidney disease.
3 Decrease in the rate of metabolism when an enzyme
inhibitor is given. {increase in the t1/2.}
4 4. Decreased renal blood flow as in cardiogenic shock,
cardiac failure or hypovolemia [hemorrhage] increases its t
½ .
Half life of some representative drugs
• Aspirin ----------4hrs
• Penicillin G-----30 min
• Doxycycline --- 20 hrs
• Digoxin---------40 hrs
• Digitoxin--------7 days
• Phenbarbitone -90hrs

More Related Content

Similar to plasma half life.pharmacology lecture .slideshare.pptx

Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
khalafpharm
 
pharmacokinetic of iv infusion
pharmacokinetic of iv infusionpharmacokinetic of iv infusion
pharmacokinetic of iv infusion
Dr.saqib habib
 

Similar to plasma half life.pharmacology lecture .slideshare.pptx (20)

Clinical pharmacokinetics
Clinical pharmacokineticsClinical pharmacokinetics
Clinical pharmacokinetics
 
Clinical pharmacokinetics & pharmacodynamics 1
Clinical pharmacokinetics & pharmacodynamics 1Clinical pharmacokinetics & pharmacodynamics 1
Clinical pharmacokinetics & pharmacodynamics 1
 
Pharmacokinetic parameters
Pharmacokinetic parametersPharmacokinetic parameters
Pharmacokinetic parameters
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Elementary pharmacokinetics jap
Elementary pharmacokinetics japElementary pharmacokinetics jap
Elementary pharmacokinetics jap
 
PK- Basic terminologies.pptx
PK- Basic terminologies.pptxPK- Basic terminologies.pptx
PK- Basic terminologies.pptx
 
Pocket Guide: Pharmacokinetics Made Easy - sample
Pocket Guide: Pharmacokinetics Made Easy - sample Pocket Guide: Pharmacokinetics Made Easy - sample
Pocket Guide: Pharmacokinetics Made Easy - sample
 
Health informathics part passive reabsorption2.pptx
Health informathics part passive reabsorption2.pptxHealth informathics part passive reabsorption2.pptx
Health informathics part passive reabsorption2.pptx
 
iv infusions.pptx
iv infusions.pptxiv infusions.pptx
iv infusions.pptx
 
Context-Sensitive Half-Time in Anaesthetic Practice
Context-Sensitive Half-Time in Anaesthetic PracticeContext-Sensitive Half-Time in Anaesthetic Practice
Context-Sensitive Half-Time in Anaesthetic Practice
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
2.pharmacokinetics
2.pharmacokinetics2.pharmacokinetics
2.pharmacokinetics
 
Sustined release and controlled release
Sustined release and controlled releaseSustined release and controlled release
Sustined release and controlled release
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
lecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptxlecture 4 Clinical pharmacokinetics.pptx
lecture 4 Clinical pharmacokinetics.pptx
 
1612188029641020.pptx
1612188029641020.pptx1612188029641020.pptx
1612188029641020.pptx
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
 
pharmacokinetic of iv infusion
pharmacokinetic of iv infusionpharmacokinetic of iv infusion
pharmacokinetic of iv infusion
 

More from ABIDOFFICIALCHANNEL

Lipids Chemistry.biovmchemistry slideshare.ootx
Lipids Chemistry.biovmchemistry slideshare.ootxLipids Chemistry.biovmchemistry slideshare.ootx
Lipids Chemistry.biovmchemistry slideshare.ootx
ABIDOFFICIALCHANNEL
 
Adverse drug reactions.pharmacology slideshare.pptx
Adverse drug reactions.pharmacology slideshare.pptxAdverse drug reactions.pharmacology slideshare.pptx
Adverse drug reactions.pharmacology slideshare.pptx
ABIDOFFICIALCHANNEL
 
1.CNS.central nervous system slideshare.pptx
1.CNS.central nervous system slideshare.pptx1.CNS.central nervous system slideshare.pptx
1.CNS.central nervous system slideshare.pptx
ABIDOFFICIALCHANNEL
 

More from ABIDOFFICIALCHANNEL (20)

BLOOD AND NERVE SUPPLY TO FACIAL REIGION.pptx
BLOOD AND NERVE SUPPLY TO FACIAL REIGION.pptxBLOOD AND NERVE SUPPLY TO FACIAL REIGION.pptx
BLOOD AND NERVE SUPPLY TO FACIAL REIGION.pptx
 
AQUEOUS 1.anatomy of eye by dr aznat ullah
AQUEOUS 1.anatomy of eye by dr aznat ullahAQUEOUS 1.anatomy of eye by dr aznat ullah
AQUEOUS 1.anatomy of eye by dr aznat ullah
 
anatomy of vitreous.by dr azmat slideshare
anatomy of vitreous.by dr azmat slideshareanatomy of vitreous.by dr azmat slideshare
anatomy of vitreous.by dr azmat slideshare
 
Inflammation Practical.slideshare.pptx.
Inflammation  Practical.slideshare.pptx.Inflammation  Practical.slideshare.pptx.
Inflammation Practical.slideshare.pptx.
 
CORYNEBACTERIUM.by Dr munir KGMC peshawarpesha
CORYNEBACTERIUM.by Dr munir KGMC peshawarpeshaCORYNEBACTERIUM.by Dr munir KGMC peshawarpesha
CORYNEBACTERIUM.by Dr munir KGMC peshawarpesha
 
Non steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptxNon steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptx
 
Pharmacology of glaucoma slideshare.pptx.
Pharmacology of glaucoma slideshare.pptx.Pharmacology of glaucoma slideshare.pptx.
Pharmacology of glaucoma slideshare.pptx.
 
Lipids Chemistry.biovmchemistry slideshare.ootx
Lipids Chemistry.biovmchemistry slideshare.ootxLipids Chemistry.biovmchemistry slideshare.ootx
Lipids Chemistry.biovmchemistry slideshare.ootx
 
Communication barriers final ppt (2).pptx
Communication barriers final ppt (2).pptxCommunication barriers final ppt (2).pptx
Communication barriers final ppt (2).pptx
 
1.INTRO TO PATHOLOGY۔SLIDESHA.RE۔PPTX۔۔۔
1.INTRO TO PATHOLOGY۔SLIDESHA.RE۔PPTX۔۔۔1.INTRO TO PATHOLOGY۔SLIDESHA.RE۔PPTX۔۔۔
1.INTRO TO PATHOLOGY۔SLIDESHA.RE۔PPTX۔۔۔
 
1.INTRO TO PATHO.slideshare.pathology pptx
1.INTRO TO PATHO.slideshare.pathology pptx1.INTRO TO PATHO.slideshare.pathology pptx
1.INTRO TO PATHO.slideshare.pathology pptx
 
Lecture-1 Introduction to hematology.slideshare.pptx
Lecture-1 Introduction to hematology.slideshare.pptxLecture-1 Introduction to hematology.slideshare.pptx
Lecture-1 Introduction to hematology.slideshare.pptx
 
Adverse drug reactions.pharmacology slideshare.pptx
Adverse drug reactions.pharmacology slideshare.pptxAdverse drug reactions.pharmacology slideshare.pptx
Adverse drug reactions.pharmacology slideshare.pptx
 
Argumentation Skills.english lecture slideshare.pptx
Argumentation Skills.english lecture slideshare.pptxArgumentation Skills.english lecture slideshare.pptx
Argumentation Skills.english lecture slideshare.pptx
 
ENZYMES -enzymes biochemistry.slideshare.pptx
ENZYMES -enzymes biochemistry.slideshare.pptxENZYMES -enzymes biochemistry.slideshare.pptx
ENZYMES -enzymes biochemistry.slideshare.pptx
 
punctuation.english slideshare.pptx english
punctuation.english slideshare.pptx englishpunctuation.english slideshare.pptx english
punctuation.english slideshare.pptx english
 
Types of Presentation.english lecture pptx
Types of Presentation.english lecture pptxTypes of Presentation.english lecture pptx
Types of Presentation.english lecture pptx
 
Phrases.english lecture.slideshare.pptx.
Phrases.english lecture.slideshare.pptx.Phrases.english lecture.slideshare.pptx.
Phrases.english lecture.slideshare.pptx.
 
1.CNS.central nervous system slideshare.pptx
1.CNS.central nervous system slideshare.pptx1.CNS.central nervous system slideshare.pptx
1.CNS.central nervous system slideshare.pptx
 
Pharmacology slideshare .pharmacology pptx
Pharmacology slideshare .pharmacology pptxPharmacology slideshare .pharmacology pptx
Pharmacology slideshare .pharmacology pptx
 

Recently uploaded

Personalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes GuàrdiaPersonalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
EADTU
 
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MysoreMuleSoftMeetup
 

Recently uploaded (20)

Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Simple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdfSimple, Complex, and Compound Sentences Exercises.pdf
Simple, Complex, and Compound Sentences Exercises.pdf
 
Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of Play
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.ppt
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf arts
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17
 
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptxMichaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx
 
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes GuàrdiaPersonalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
 
Including Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdfIncluding Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdf
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
PANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxPANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptx
 
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learning
 
OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 

plasma half life.pharmacology lecture .slideshare.pptx

  • 2. DEFINITION • It is the time period required for the amount of or the concentration of a drug to fall to 50 % of the earlier measurement. • or • It is the time required to achieve half of the concentration of drug in the plasma administered via any route.
  • 3. Types of half life • Biological half life • Plasma half life • Distribution half life • Elimination half life
  • 4. BIOLOGICAL HALF LIFE; • It is the general term which implies to the time period in which the initial concentration of the drug decreases by one half.[it is not specific for any anatomical compartment or for any process of elimination].
  • 5. PLASMA HALF LIFE • It is the time required to decrease the drug concentration in the plasma to one half of its initial concentration. • or • To achieve half of the concentration the drug in the plasma after administration via any route. • It is denoted by t1/2
  • 6. DISTRIBUTION HALF LIFE • It is the time taken to decrease the drug concentration in the plasma to one half of its initial concentration by virtue of its distribution [to the other compartments].
  • 7. ELIMINATION HALF LIFE It is the time taken when one half of the drug appears in the urine or bile. • Elimination half life is expressed as • t ½= 0.693 X Vd/CL • Where CL is the clearence and Vd is the volume of distribution.
  • 8. Contd Changes in the plasma conc. On starting , altering or stopping the drug administration can be predicted by plasma half life.
  • 9. INFUSION AT A CONSTANT RATE • When a drug is infused at a constant rate, the rate of elimination becomes equal to the rate of administration and a steady state is achieved called the STEADY STATE CONCENTRATION. • This is depicted by a PLATEAU on the conc time curve.
  • 10. ON WITHDDRAWL OF THE DRUG • On stopping the drug , the plasma conc goes on decreasing as follows: • In the first half life [ t ½] = To 5o% • In the second half life [ 2t ½] = 25% • In the third half life [3t ½] = 12.5% • In the fourth half life [4t ½] = 6.25% • In the fifth half life [5t ½] = 3.12% • Of the original steady state conc .
  • 11. SIGNIFICANCE OF THE HALF LIFE • To determine the duration of action of the drug. • To evaluate the dose [by the Vd, protien binding and the elimination] • To determine the frequency of drug administration. • To calculate the loading dose • [ t ½ x tc x CL/o.693] • To determine the time required to reach the steady concentrtation. • To know about the maintenance dose • [Vd x Css ½ x o.693] • To find the defect in the distribution, metabolism or clearence[to asses the disease]
  • 12. contd • When the protein binding of the drug is more, it will increase the plasma half ,unless the drug is excreted by active secretion as in penicillin G. • It gives an idea of the time to attain a steady state and also the time taken for the elimination.
  • 13. • IT HELPS IN CALCULATING THE TOTAL CLEARENCE i.e • CL = O.693 X Vd / t ½
  • 14. FACTORS EFFECTING HALF LIFE 1 Concurrent administration of another drug that displaces the first drug from albumin decreases its t ½. 2 low extraction ratio increases the half life as in the liver and kidney disease. 3 Decrease in the rate of metabolism when an enzyme inhibitor is given. {increase in the t1/2.} 4 4. Decreased renal blood flow as in cardiogenic shock, cardiac failure or hypovolemia [hemorrhage] increases its t ½ .
  • 15. Half life of some representative drugs • Aspirin ----------4hrs • Penicillin G-----30 min • Doxycycline --- 20 hrs • Digoxin---------40 hrs • Digitoxin--------7 days • Phenbarbitone -90hrs